Feature | June 12, 2009

Isotope Crisis Highlights Timeliness of SNM Meeting

Isotope Crisis Highlights Timeliness of SNM Meeting

June 12, 2009 - With the Chalk River* nuclear reactor in Laurentian Hills, Ontario, Canada, shutdown, a reactor that supplies one-third** of the nuclear isotopes to the world, it was very timely when Canadian Prime Minister Stephen Harper welcomed the SNM annual meeting to Toronto, Canada, emphasizing the importance of molecular imaging to the future practice of medicine.

While the reactor is down for an undetermined amount of time, patients in North America requiring nuclear medicine procedures for diagnosing cancer, and neurological and cardiovascular diseases will face serious delays in medical treatment. As such, the medical isotope crisis places unprecedented importance on the SNM Annual Meeting, which called a press conference to address the issue: “Current Developments in the Medical Isotope Crisis and Molecular Imaging Research Breakthroughs,” on Monday, June 15, 11:30 a.m. to 12:45 p.m., in room 810 of the convention center.

The panel of top molecular imaging researchers, in addition to SNM President Robert W. Atcher, Ph.D, M.B.A., President-Elect Michael M. Graham, M.D., Ph.D, Peter S. Conti, M.D., Ph.D, and Henry N. Wagner, Jr., M.D., Johns Hopkins University, will discuss the latest developments surrounding the international medical isotope crisis; and announce major molecular imaging breakthroughs in the detection and treatment of cancers, heart and brain diseases.

Imaging Technology News will be providing all of the breaking news from the 2009 SNM Annual Meeting on ITNonline.net.

* The Chalk River nuclear reactor in Laurentian Hills, Ontario, Canada, is managed by the Atomic Energy of Canada Limited (AECL), a Canadian federal Crown corporation, that is a nuclear technology and engineering company that designed and developed the CANDU nuclear power reactor.
** According to medical doctor Jean-Luc Urbain, president of the Canadian Association of Nuclear Medicine, the Chalk River reactor supplies about 60 percent of the medical isotopes in the world, and the countries that will be most affected by the shortage are Canada and the U.S.

Read the 2017 article "FDA Clears Path for First Domestic Supply of Tc-99m Isotope." 

For more information: www.snm.org

Related Content

Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...